QGEN · NYSE
Qiagen (QGEN) Stock Price & Fundamentals
Qiagen (QGEN) closed at $615.27 on Oct 9, 2026, up 0.55% from the previous close of $611.88.
Share price, past year
1Y +34.60%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $615.27 |
| Sep 30, 2026 | $601.28 |
| Aug 31, 2026 | $622.35 |
| Jul 31, 2026 | $625.51 |
| Jun 30, 2026 | $585.80 |
| May 29, 2026 | $555.95 |
| Apr 30, 2026 | $538.55 |
| Mar 31, 2026 | $522.48 |
| Feb 27, 2026 | $488.25 |
| Jan 30, 2026 | $471.55 |
| Dec 31, 2025 | $479.00 |
| Nov 28, 2025 | $488.56 |
| Oct 31, 2025 | $461.06 |
Key statistics
- Market cap
- $133.46B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 216.9M
- Dividend yield
- —
- 52-week range
- $451.28 – $633.01
Qiagen's market cap is $133.46B, based on a share price of $615.27 and 216.9M shares outstanding as of Dec 31, 2025.
Financials
Qiagen reported revenue of $2.09B for fiscal 2025, up 5.65% from fiscal 2024.
Qiagen earned net income of $424.88M in fiscal 2025, a net margin of 20.3%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.09B | +5.7% | $424.88M | 20.3% | $1.94 | $453.28M |
| FY2024ended Dec 31, 2024 | $1.98B | +0.7% | $83.59M | 4.2% | $0.37 | $506.38M |
| FY2023ended Dec 31, 2023 | $1.97B | −8.2% | $341.30M | 17.4% | $1.48 | $309.75M |
| FY2022ended Dec 31, 2022 | $2.14B | −4.9% | $423.21M | 19.8% | $1.84 | $586.04M |
| FY2021ended Dec 31, 2021 | $2.25B | +20.4% | $512.60M | 22.8% | $2.21 | $449.10M |
| FY2020ended Dec 31, 2020 | $1.87B | +22.5% | $359.19M | 19.2% | $1.53 | $325.02M |
| FY2019ended Dec 31, 2019 | $1.53B | +1.6% | −$41.46M | −2.7% | −$0.18 | $212.89M |
| FY2018ended Dec 31, 2018 | $1.50B | +6.0% | $190.38M | 12.7% | $0.82 | $249.72M |
| FY2017ended Dec 31, 2017 | $1.42B | +6.0% | $40.39M | 2.9% | $0.17 | $196.70M |
| FY2016ended Dec 31, 2016 | $1.34B | — | $80.40M | 6.0% | $0.34 | $267.07M |
Company profile
- Name
- Qiagen N.V.
- Ticker
- QGEN
- Exchange
- NYSE
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Hulsterweg 82, Pl Venlo, 5912 PL
- Incorporated in
- P7
- Fiscal year ends
- December
- SEC CIK
- 0001015820
Frequently asked questions
What is Qiagen's stock price?
Qiagen (QGEN) closed at $615.27 on Oct 9, 2026, up 0.55% from the previous close of $611.88.
What is Qiagen's market cap?
Qiagen's market cap is $133.46B, based on a share price of $615.27 and 216.9M shares outstanding as of Dec 31, 2025.
How much revenue does Qiagen make?
Qiagen reported revenue of $2.09B for fiscal 2025, up 5.65% from fiscal 2024.
Sources and methodology
Fundamentals come from Qiagen N.V.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures